CELZ Latest Press Releases

-- January 13, 2026 --

Creative Medical Technology Holdings Reaches Major Clinical Inflection Point with Positive Interim Data from ADAPT Trial and CELZ-201 (Olastrocel) in the Treatment of Chronic Lower Back Pain Globe Newswire 9:15 AM

-- January 6, 2026 --

Creative Medical Technology Holdings Receives Regulatory Approval for BioDefense Burn Pit Initiative Globe Newswire 9:15 AM

-- December 17, 2025 --

Creative Medical Technology Holdings, Inc. Completes Enrollment in FDA-Cleared ADAPT Trial for CELZ-201-Olastrocel, Marking Major Clinical Inflection Point Globe Newswire 9:15 AM

-- December 2, 2025 --

Creative Medical Technology Holdings Announces World Health Organization Approval of "olastrocel" as INN for Lead Allogeneic Cell Therapy CELZ-201 Globe Newswire 9:15 AM

-- October 30, 2025 --

Creative Medical Technology Holdings, Inc. Ignites Next-Gen Regenerative BioDefense Initiative for U.S. Veterans Exposed to Burn Pits Globe Newswire 9:15 AM

-- October 29, 2025 --

Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $4.2 Million Gross Proceeds Globe Newswire 9:00 AM

-- October 27, 2025 --

Creative Medical Technology Holdings Issues Letter to Shareholders Globe Newswire 8:15 AM

-- October 7, 2025 --

Creative Medical Technology Holdings Congratulates 2025 Nobel Laureates for Regulatory T Cell Breakthroughs Globe Newswire 9:15 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software